Skip to content

Top 10 Pharma Stocks in India for August 2026

Sector Alpha's August 2026 ranking of pharma stocks worth ₹2,000 crore or more, from the weekly scan to 4 September 2026, put Neuland Laboratories (81/100), Acutaas Chemicals (77/100) and Shukra Pharmaceuticals (75/100) at the top. The score weighs growth, business quality, valuation against history and price strength. Source: Sector Alpha weekly scan.

  1. 1Neuland Laboratories81scoreGrowthQualityValuationPriceGrowth 96 · Quality 80 · Valuation 59 · Price strength 79
  2. 2Acutaas Chemicals77scoreGrowthQualityValuationPriceGrowth 91 · Quality 80 · Valuation 45 · Price strength 79
  3. 3Shukra Pharmaceuticals75scoreGrowthQualityValuationPriceGrowth 87 · Quality 77 · Valuation 46 · Price strength 81
  4. 4IOL Chemicals & Pharmaceuticals73scoreGrowthQualityValuationPriceGrowth 82 · Quality 50 · Valuation 67 · Price strength 95
  5. 5Senores Pharmaceuticals72scoreGrowthQualityValuationPriceGrowth 93 · Quality 68 · Valuation 47 · Price strength 67
  6. 6Glenmark Pharmaceuticals71scoreGrowthQualityValuationPriceGrowth 88 · Quality 73 · Valuation 62 · Price strength 47
  7. 7Gland Pharma70scoreGrowthQualityValuationPriceGrowth 75 · Quality 56 · Valuation 70 · Price strength 77
  8. 8Laurus Labs70scoreGrowthQualityValuationPriceGrowth 92 · Quality 73 · Valuation 27 · Price strength 70
  9. 9Bliss GVS Pharma68scoreGrowthQualityValuationPriceGrowth 83 · Quality 59 · Valuation 31 · Price strength 88
  10. 10Ipca Laboratories68scoreGrowthQualityValuationPriceGrowth 75 · Quality 63 · Valuation 53 · Price strength 74

Not frozen yet: this August 2026 ranking is worked out again from the stored weekly scores each time the page is built, so it follows today's rule. Once a month is frozen, it never changes.

See the latest pharma stocks ranking and full list.

Next month →

Disclosure: Sector Alpha is not a SEBI-registered research analyst. This page is information and education only, not a recommendation to buy, sell or hold any security. No price targets are given. Data: NSE prices through our weekly pipeline. Past performance does not indicate future results.

More lists

All 20 lists, grouped